The Impact of Antiepileptic Therapy on Anesthetic Requirements and Postoperative Pain in Patients with Pharmacoresistant Focal Epilepsy: a Retrospective Study

Mukhit Dossov 1 * , Azhar Zhailauova 2, Nazira Bekenova 3, Alisher Aitkalyev 3, Serik Seitenov 4
More Detail
1 Anesthesiology and ICU Department, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan
2 Anesthesiology and ICU Residency Department, Nazarbayev University School of Medicine, Astana, Kazakhstan
3 Department of Science, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan
4 Deputy head of the Medical Centre Hospital of President’s Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 23, Issue 4, pp. 4-13. https://doi.org/10.23950/jcmk/18978
OPEN ACCESS 2314 Views 13 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, M.D.; methodology, M.D. and S.S.; validation, M.D. and N.B.; formal analysis, N.B., A.Z. and M.D.; investigation, M.D. and N.B.; resources, A.A.; data curation, S.S.; writing – original draft preparation, M.D. and A.Z.; writing – review and editing, M.D., A.Z. and A.A.; visualization, N.B. and A.A; supervision, S.S.; project administration, M.D.; funding acquisition, M.D., A.A. All authors have read and agreed to the published version of the manuscript.

Data availability statement: The data presented in this study are available on request from the corresponding author due to the protection of primary data.

Artificial Intelligence (AI) Disclosure Statement: The authors declare no AI Tools used for preparation of this work.

ABSTRACT

ABSTRACT
Background: Patients with pharmacoresistant focal epilepsy (PRE) are exposed to long-term antiepileptic drug (AED) therapy, which may influence anesthetic pharmacology and postoperative pain. However, evidence regarding the perioperative effects of chronic AED treatment remains scarce. The study aims to investigate the association of AED regimen, epilepsy duration, anesthetic consumption, and surgery with postoperative pain in patients with pharmacoresistant focal epilepsy.
Methods: The retrospective cohort study included 92 participants with pharmacoresistant focal epilepsy who underwent neurosurgical intervention between 2019 and 2024. Patients were stratified according to AED regimen into carbamazepine monotherapy (n=27), carbamazepine plus levetiracetam (n=44), and other AED combinations (n=21). Intraoperative anesthetic consumption, postoperative visual analogue scale (VAS) pain scores, analgesic requirements, and perioperative outcomes were compared. Predictors of postoperative pain were evaluated using multivariable logistic regression analysis.  
Results: Patients receiving combination AED therapy had significantly longer epilepsy duration than those receiving carbamazepine monotherapy (median 16–18 vs. 8 years, p<0.01). Intraoperative consumption of fentanyl, propofol, sevoflurane, and neuromuscular blocking agents did not differ among treatment groups (all p>0.05). Postoperative pain occurred in 58.7% of patients, with similar VAS trajectories, analgesic requirements, and time to first analgesic request across groups. Surgery type was not associated with postoperative pain in either univariate or multivariable analyses. Multivariable logistic regression demonstrated no independent association between postoperative pain and AED regimen, intraoperative fentanyl dose, sex, or surgical procedure (all p>0.05). Sensitivity analysis limited to patients receiving carbamazepine or levetiracetam as the primary AED yielded consistent results, although levetiracetam showed a non-significant trend toward lower odds of postoperative pain compared with carbamazepine (adjusted OR 0.47, 95% CI 0.19–1.18).
Conclusions: Long-term AED regimen, epilepsy duration, and surgery type were not independently associated with anesthetic requirements or early postoperative pain in patients undergoing surgery for pharmacoresistant focal epilepsy. Standardized perioperative anesthesia and postoperative analgesia appear to provide effective pain control regardless of chronic AED therapy. Larger prospective multicenter studies are needed to confirm these findings and evaluate the perioperative effects of individual AEDs.
Keywords: pharmacoresistant focal epilepsy, antiepileptic drugs, carbamazepine, levetiracetam, postoperative pain, anesthesia, epilepsy surgery, neurosurgery.

CITATION

Dossov M, Zhailauova A, Bekenova N, Aitkalyev A, Seitenov S. The Impact of Antiepileptic Therapy on Anesthetic Requirements and Postoperative Pain in Patients with Pharmacoresistant Focal Epilepsy: a Retrospective Study. J CLIN MED KAZ. 2026;23(4):4-13. https://doi.org/10.23950/jcmk/18978

REFERENCES

  • Ioannou P, Foster DL, Sander JW, Dupont S, Gil-Nagel A, Drogon O’Flaherty E, Alvarez-Baron A, Medjedovic J. The burden of epilepsy and unmet need in people with focal seizures. Brain Behav. 2022; 12(9): e2589. https://doi.org/10.1002/brb3.2589.
  • Jaxybayeva A, Kalinina D. Understanding the Healthcare Landscape for Pediatric Epilepsy Patients in Kazakhstan: Challenges and Opportunities. Journal of Clinical Medicine of Kazakhstan. 2025; 22(6): 103-108. https://doi.org/10.23950/jcmk/17474.
  • Villanueva V, Carreño M, Gil-Nagel A, Serrano-Castro PJ, Serratosa JM, Toledo M, Álvarez-Baróng E, Gilh A, Subías-Labazuyh S. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA). Epilepsy and Behavior. 2021; 122: 108222. https://doi.org/10.1016/j.yebeh.2021.108222.
  • Mehdizadeh A, Barzegar M, Negargar S, Yahyavi A, Raeisi S. The current and emerging therapeutic approaches in drug-resistant epilepsy management. Acta Neurol Belg. 2019; 119: 155–162. https://doi.org/10.1007/s13760-019-01120-8.
  • Shankar R, Marston XL, Danielson V, Do Rego B, Lasagne R, Williams O, Groves L. Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011–2021. J Neurol. 2024; 271: 2473–2483. https://doi.org/10.1007/s00415-023-12165-4.
  • Gratrix AP, Enright SM. Epilepsy in anaesthesia and intensive care. Continuing Education in Anaesthesia, Critical Care and Pain. 2005; 5(4): 118–121. https://doi.org/10.1093/bjaceaccp/mki032.
  • Larkin CM, O’Brien DF, Maheshwari D. Anaesthesia for epilepsy surgery. BJA Educ. 2019; 19: 383–389. https://doi.org/10.1016/j.bjae.2019.08.001.
  • Dossov M, Seitenov S, Bekenova N, Kuatbay G. The Influence of Disease Duration in Pharmacoresistant Focal Epilepsy and Type of Antiepileptic Therapy on Intraoperative Infusion Therapy Parameters. Journal of Clinical Medicine of Kazakhstan. 2025; 22(6): 4–9. https://doi.org/10.23950/jcmk/17360.
  • Sainburg LE, Englot DJ, Morgan VL. The impact of resective epilepsy surgery on the brain network: evidence from post-surgical imaging. Brain. 2025; 148(6): 1866–1875. https://doi.org/10.1093/brain/awaf026.
  • Cohen H, Mahajna G, Ben-Shushan T, Matok I, Eyal S. The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta-analysis. Epilepsia. 2024; 65(2): 445–455. https://doi.org/10.1111/epi.17822.
  • Pacchioni A, Yano JK, Assirati JA. Anesthesia for epilepsy surgery. International Journal of Clinical Anesthesia and Research. 2023; 7(1): 001–005. https://doi.org/10.29328/journal.ijcar.1001021.
  • Zhang Y, Li H, Zhang B, Zhang J, Li C. Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis. Front Neurol. 2025; 16: 1543905. https://doi.org/10.3389/fneur.2025.1543905.
  • In J, Huynh K, Luong J, Sooknanan D, Kinjo S. The Role of Antiepileptics for Postoperative Pain Management. Perioperative Pain Management: A Clinical Guide, 2024, p. 575–598. https://doi.org/10.1007/978-3-031-67648-2_37.
  • Venkatraghavan L, Bhardwaj S, Banik S, Chowdhury T, McAndrews MP, Valiante T. Emergence Patterns from General Anesthesia after Epilepsy Surgery: An Observational Pilot Study. Asian J Neurosurg. 2023; 18(03): 516–521. https://doi.org/10.1055/s-0043-1771365.
  • Fiore G, Porto E, Pluderi M, Ampollini AM, Borsa S, Legnani FG, Giampiccolo D, Miserocchi A, Bertani GA, DiMeco F, Locatelli M. Prevention of Post-Operative Pain after Elective Brain Surgery: A Meta-Analysis of Randomized Controlled Trials. Medicina (Lithuania). 2023; 59: 831. https://doi.org/10.3390/medicina59050831.
  • Pour-Rashidi A, Zandpazandi S, Hsu S, Shakeri A, Safari N, Apuzzo M, Stieg PE. Comparative analysis of monotherapy versus duotherapy with antiseizure medications for intraoperative and early postoperative seizure control in glioma patients undergoing awake craniotomy. J Neurooncol. 2025; 175: 303–312. https://doi.org/10.1007/s11060-025-05133-7.
  • Negm EM, Younus MA, Morsy AA, El Gammal SMS, El-Harrisi MA, Sameaa FAA, Rashad RAM, Elserafy TS, Gouda AM. Opioid-sparing multimodal analgesia for post-craniotomy pain: a randomized, double-blind, placebo-controlled trial. BMC Anesthesiol. 2025; 25: 437. https://doi.org/10.1186/s12871-025-03306-5.
  • Ahmad S, Khanna R, Onyewuenyi AC, Panos N, Breslin R, Sani S. Efficacy of an opioid-sparing analgesic protocol in pain control after less invasive cranial neurosurgery. Pain Rep. 2021; 6(3): e948. https://doi.org/10.1097/PR9.0000000000000948.
  • Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G. Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13: e58–e68. https://doi.org/10.1016/S1470-2045(12)70040-2.
  • Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal P V., Keane KA, Tesoro EP, Elswick RK. The Richmond Agitation–Sedation Scale. Am J Respir Crit Care Med. 2002;166(10): 1338–1344. https://doi.org/10.1164/rccm.2107138.
  • Chae KL, Park SY, Hong JI, Yim WJ, Lee SC, Chung CJ. The effect of gender and age on postoperative pain in laparoscopic cholecystectomy: a prospective observational study. Anesth Pain Med (Seoul). 2019; 14(3): 364–369. https://doi.org/10.17085/apm.2019.14.3.364.
  • Bjørke AB, Nome CG, Falk RS, Gjerstad L, Taubøll E, Heuser K. Evaluation of long-term antiepileptic drug use in patients with temporal lobe epilepsy: Assessment of risk factors for drug resistance and polypharmacy. Seizure. 2018; 61: 63–70. https://doi.org/10.1016/j.seizure.2018.07.011.
  • Hosny H, Elfayoumy N, Adly M, Abdelghany H. Genetic generalized epilepsy: factors associated with drug resistance polytherapy. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2023; 59: 4. https://doi.org/10.1186/s41983-022-00604-4.
  • Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006; 61: 246–255. https://doi.org/10.1111/j.1365-2125.2005.02529.x.
  • Maranhão MVM, Gomes EA, Carvalho EP. Epilepsy and Anesthesia. Rev Bras Anestesiol. 2011; 61(2): 232–254. https://doi.org/10.1590/S0034-70942011000200013.
  • Perks A, Cheema S, Mohanraj R. Anaesthesia and epilepsy. Br J Anaesth. 2012; 108: 562–571. https://doi.org/10.1093/bja/aes027.
  • Tempelhoff R, Modica PA, Spitznagel EL. Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy. Canadian Journal of Anaesthesia. 1990; 37: 327–332. https://doi.org/10.1007/BF03005584.
  • Soriano SG, Martyn JAJ. Antiepileptic-Induced Resistance to Neuromuscular Blockers: Mechanisms and Clinical Significance. Clin Pharmacokinet. 2004; 43: 71–81. https://doi.org/10.2165/00003088-200443020-00001.
  • Richard A, Girard F, Girard DC, Boudreault D, Chouinard P, Moumdjian R, Bouthilier A, Ruel M, Couture J, Varin F. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg. 2005; 100(2): 538–544. https://doi.org/10.1213/01.ANE.0000143333.84988.50.
  • Jeon Y-J, Kim M. Effect of levetiracetam on rocuronium duration in patients undergoing cerebrovascular surgery. Anesth Pain Med (Seoul). 2018; 13(4): 409–414. https://doi.org/10.17085/apm.2018.13.4.409.
  • Young A, Buvanendran A. Pain, Acute and Postoperative. Encyclopedia of the Neurological Sciences. 2014, p. 707–713. https://doi.org/10.1016/B978-0-12-385157-4.00233-5.
  • Galvin IM, Levy R, Day AG, Gilron I. Pharmacological interventions for the prevention of acute postoperative pain in adults following brain surgery. Cochrane Database of Systematic Reviews. 2019; 11: CD011931. https://doi.org/10.1002/14651858.CD011931.pub2.
  • Ayoub LJ, Honigman L, Barnett AJ, McAndrews MP, Moayedi M. Mechanical pain sensitivity is associated with hippocampal structural integrity. Pain. 2024; 165(9): 2079–2086. https://doi.org/10.1097/j.pain.0000000000003221.
  • Singh D, Kumar S, LNU B, Priye S, Prakash J. Preemptive Levetiracetam Decreases Postoperative Pain: A Double-Blind, Randomised, Control Trial. Cureus. 2023; 15(1): e33281. https://doi.org/10.7759/cureus.33281.
  • Micov A, Tomić M, Popović B, Stepanović-Petrović R. The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: Mechanism of action. Br J Pharmacol. 2010; 161: 384–392. https://doi.org/10.1111/j.1476-5381.2010.00877.x.
  • Caton L, Bolzon M, Boschiero D, Thayer JF, Gidron Y. Pre-surgical heart-rate variability strongly predicts less post-operative pain in patients with epilepsy. J Psychosom Res. 2021; 145: 110421. https://doi.org/10.1016/j.jpsychores.2021.110421.